CNTX
NASDAQ · Pharmaceuticals
Context Therapeutics Inc
$2.31
-0.02 (-0.86%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+925.1% upside
Low Target
$16.27
Average Target
$23.68
High Target
$31.54
Current Price
$2.31
Current
$2.31
$2.31
Target
$23.68
$23.68
$16.27
$23.68 avg
$31.54
Scenario Analysis
Bear Case
$16.27
604.3%
Low target
Base Case
$23.68
+925.1%
Avg target
Bull Case
$31.54
+1,265.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.62
-36.2% from high
52-Week Low
$0.49
+371.4% from low
Target vs 52W High
$23.68
+554.1% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-0.12
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals